Poly acyl nucleon inhibitors and macrocathode protein inhibitors and their mixtures for hepatitis C, liver fibrosis and liver function changes

摘要

The embodiments mentioned in the application refer to the salts or recipes that may include hepatitis C virus polymerase inhibitors, or be medically acceptable and inhibit hepatitis C virus protein, or the ingredients of acceptable salts or recipes. Other implementations described relate to methods of treating a disease condition, such as hepatitis C virus infection, liver fibrosis, and / or changes in liver function with hepatitis C virus polymerase inhibitors.Or the salt or prospects acceptable to the drug of hepatitis C virus protein, or the salt or prospects acceptable to the drug.